Literature DB >> 16416346

TSH may not be a good marker for adequate thyroid hormone replacement therapy.

Maria Alevizaki1, Emily Mantzou, Adriana T Cimponeriu, Calliope C Alevizaki, Dimitri A Koutras.   

Abstract

The objective of this study was to evaluate parameters of thyroid function and indices of peripheral thyroid hormone action (such as SHBG) in patients whose hypothyroidism was considered well controlled under current criteria. Eighty-five patients with T4-treated hypothyroidism, 28 of whom had athyria, were compared with 114 normal individuals with the same TSH levels. T3 levels were significantly lower in hypothyroidism although mean T4 and fT4 levels were significantly higher. Furthermore, mean SHBG levels were significantly lower in hypothyroidism independently of age. The difference remained when stricter criteria for adequate treatment were applied (TSH < 2.5 microgU/ml). Significant negative correlations were found between logTSH and T3. The slopes of the regression lines of T3 to TSH were significantly different in the control group and the hypothyroid group: thus, for the same TSH levels, T3 levels were lower in the hypothyroid group. We conclude that patients with T4-treated hypothyroidism have lower T3 levels, lower T3/T4 ratio and lower SHBG than normal individuals with the same TSH, perhaps indicating relative tissue hypothyroidism in the liver. TSH levels used to monitor substitution, mostly regulated by intracellular T3 in the pituitary, may not be such a good indicator of adequate thyroid hormone action in all tissues. The co-administration of T3 may prove more effective in this respect, provided novel suitable preparations are developed. Until this is accomplished, substitution in hypothyroidism should aim at low normal TSH, to ensure normal T3 levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16416346     DOI: 10.1007/s00508-005-0421-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  17 in total

Review 1.  Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level.

Authors:  Jacqueline Jonklaas
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-10       Impact factor: 3.243

2.  TSH may not be a good marker for adequate thyroid hormone replacement therapy.

Authors:  Anton Staudenherz; Helmut Sinzinger
Journal:  Wien Klin Wochenschr       Date:  2006-06       Impact factor: 1.704

3.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 4.  Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.

Authors:  Wilmar M Wiersinga
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

5.  2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism.

Authors:  Wilmar M Wiersinga; Leonidas Duntas; Valentin Fadeyev; Birte Nygaard; Mark P J Vanderpump
Journal:  Eur Thyroid J       Date:  2012-06-13

6.  3,3'-Diiodothyronine concentrations in hospitalized or thyroidectomized patients: results from a pilot study.

Authors:  Jacqueline Jonklaas; Anpalakan Sathasivam; Hong Wang; David Finigan; Offie P Soldin; Kenneth D Burman; Steven J Soldin
Journal:  Endocr Pract       Date:  2014-08       Impact factor: 3.443

7.  Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis.

Authors:  Elizabeth A McAninch; Kumar B Rajan; Corinne H Miller; Antonio C Bianco
Journal:  J Clin Endocrinol Metab       Date:  2018-08-15       Impact factor: 5.958

8.  Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine.

Authors:  Joao Pedro Werneck de Castro; Tatiana L Fonseca; Cintia B Ueta; Elizabeth A McAninch; Sherine Abdalla; Gabor Wittmann; Ronald M Lechan; Balazs Gereben; Antonio C Bianco
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

9.  Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients.

Authors:  Damiano Gullo; Adele Latina; Francesco Frasca; Rosario Le Moli; Gabriella Pellegriti; Riccardo Vigneri
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

10.  Peripheral markers of thyroid function: the effect of T4 monotherapy vs T4/T3 combination therapy in hypothyroid subjects in a randomized crossover study.

Authors:  Ulla Schmidt; Birte Nygaard; Ebbe Winther Jensen; Jan Kvetny; Anne Jarløv; Jens Faber
Journal:  Endocr Connect       Date:  2013-02-08       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.